DUBLIN, May 20, 2022--(BUSINESS WIRE)--The "Dental CAD/CAM Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Type, Components, Application and End User" report has been added to ResearchAndMarkets.com's offering.
According to this report the market is expected to grow from US$ 1,829.77 million in 2021 to US$ 3,447.12 million by 2028; it is estimated to grow at a CAGR of 9.5% from 2021 to 2028.
The report highlights trends prevailing in the market and factors governing the growth of the dental CAD/CAM market. The rising adoption of CAD/CAM technology in dentistry accelerates the overall market revenue during the forecast period. However, the high cost of dental CAD/CAM in emerging nations limits market potential. The lack of skilled professionals in dentistry hinders the overall market size and growth during the forecast period.
Computer-aided design (CAD) and computer-aided manufacturing (CAM) are innovative digital systems capable of scanning prepared teeth intended for receiving crowns, bridges, inlays, and other restorations. With the advent of technologies and potential applications, dentistry is one application area that has gained the highest market share in the last few years.
For example, CAD/CAM systems such as the E4D system offer a better, faster, and more convenient method for fabricating restorations.
Additionally, several major dental schools in the US adopted CAD/CAM technology intended for both education and clinical patient care. Further, the utility of CAD/CAM technology improves the experience of both the professional and patient by reducing patient visits, increasing efficiency, contributing to a positive practice environment, and clinical productivity. Such factors ultimately contribute to the overall market growth and revenue during the forecast period.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the dental CAD/CAM market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the global dental CAD/CAM market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Increasing Oral Diseases and Geriatric Population
Rising Adoption of Chair-Side CAD/CAM Systems
High Cost of CAD/CAM System and Lack of Reimbursements
Increasing Developments and Product Launches
For more information about this report visit https://www.researchandmarkets.com/r/qyo55h
View source version on businesswire.com: https://www.businesswire.com/news/home/20220520005337/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.
What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.
Stop investing in mediocre businesses. Buy the best, instead.
Julian Bridgen, co-founder and president of Macro Intelligence 2 Partners, joins Yahoo Finance Live to discuss this week's market action and whether or not it will carry over into next week, the Fed, and inflation.
Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th
The market is unstable. Your portfolio doesn’t need to be.
Artificial intelligence (AI)-based loan determination company Upstart Holdings (NASDAQ: UPST) and its shareholders alike have had a rough 2022. Upstart caught fire among investors because of its AI-based service that it touts as a more accurate judge of creditworthiness than the FICO score and standard bank determinations. One of the main concerns investors had with Upstart's quarter was the number of loans it held for sale on its own balance sheet this quarter.
The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.
The stock market ended its multiweek losing streak, and like a sports team that finally got a win, it’s worth celebrating. It just doesn’t mean the team—or this stock market—is any good. “Stocks finally enjoyed a strong bounce this week,” writes Canaccord Genuity analyst Martin Roberge.
In this article, we will discuss some of the notable stocks analysts are upgrading today. To take a look at some more stocks that are being upgraded, go to Analysts Are Upgrading These 5 Stocks on Friday. The US market closed in the green for the first time in the last seven weeks as positive […]
The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.
A key measure of U.S. inflation rose just 0.2% in April to mark the smallest increase in a year and a half, aided by lower gas prices. Yet there were other hints that a surge in U.S. inflation might be abating.
In this article, we discuss the 10 stocks that Jim Cramer and hedge funds agree on. If you want to read about some more stocks that Jim Cramer and hedge funds agree on, go directly to Jim Cramer and Hedge Funds Agree on These 5 Stocks. In the past few weeks, Jim Cramer, the journalist […]
Shares of Moderna (NASDAQ: MRNA) were jumping 7.5% higher as of 11:30 a.m. ET on Friday. Instead, Moderna appears to be benefiting from the overall stock market bounce. Good news for the overall stock market tends to be good news for Moderna.
The stock market is a game of risk and calculation, and in recent months the risks are mounting. The first quarter of 2022 showed a net negative GDP growth rate, a contraction of 1.4%; another contraction in Q2 will indicate a recession. Wall Street’s experts are trying to look ahead, to see through the fog of uncertainty and get some feel for where things are going. Covering the market for Morgan Stanley, chief US equity strategist Michael Wilson believes that we’ll dodge the recession bullet –
Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.
Nikola (NASDAQ: NKLA) hasn't posted any significant news since it reported first-quarter earnings earlier this month. Early in Friday's trading session, Nikola shares were 19.6% higher for the week, according to data provided by S&P Global Market Intelligence. More than 20% of Nikola's outstanding shares were sold short, as of mid-May. And because a large number of those shares are held by company executives or in its treasury, 36.5% of Nikola's share float were being shorted by investors, according to MarketWatch.
Wood's flagship Ark Innovation ETF has fallen 52% this year as technology companies have tumbled.
A weekly look at the most important moves and news in crypto and what's on the horizon in digital assets.